TARO-SUNITINIB DIN 02524058
Status: Marketed
Holder: TARO PHARMACEUTICALS INC
Molecule: SUNITINIB (SUNITINIB MALATE)
Available to quote
Health Canada record
| Active ingredient(s) | SUNITINIB (SUNITINIB MALATE) 12.5 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01EX01 SUNITINIB |
| Original market date | 17-Jan-2023 |
| Current status date | 17-Jan-2023 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SUNITINIB (SUNITINIB MALATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02532190 | AURO-SUNITINIB | AURO PHARMA INC | Capsule | SUNITINIB (SUNITINIB MALATE) 12.5 MG | Marketed |
| 02532220 | AURO-SUNITINIB | AURO PHARMA INC | Capsule | SUNITINIB (SUNITINIB MALATE) 50 MG | Marketed |
| 02532212 | AURO-SUNITINIB | AURO PHARMA INC | Capsule | SUNITINIB (SUNITINIB MALATE) 37.5 MG | Approved |
| 02532204 | AURO-SUNITINIB | AURO PHARMA INC | Capsule | SUNITINIB (SUNITINIB MALATE) 25 MG | Marketed |
| 02548038 | EUGIA-SUNITINIB | EUGIA PHARMA INC. | Capsule | SUNITINIB (SUNITINIB MALATE) 12.5 MG | Approved |
| 02548062 | EUGIA-SUNITINIB | EUGIA PHARMA INC. | Capsule | SUNITINIB (SUNITINIB MALATE) 50 MG | Approved |
| 02548054 | EUGIA-SUNITINIB | EUGIA PHARMA INC. | Capsule | SUNITINIB (SUNITINIB MALATE) 37.5 MG | Approved |
| 02548046 | EUGIA-SUNITINIB | EUGIA PHARMA INC. | Capsule | SUNITINIB (SUNITINIB MALATE) 25 MG | Approved |
| 02552906 | NAT-SUNITINIB | NATCO PHARMA (CANADA) INC | Capsule | SUNITINIB (SUNITINIB MALATE) 25 MG | Marketed |
| 02539284 | NAT-SUNITINIB | NATCO PHARMA (CANADA) INC | Capsule | SUNITINIB (SUNITINIB MALATE) 50 MG | Marketed |
| 02552892 | NAT-SUNITINIB | NATCO PHARMA (CANADA) INC | Capsule | SUNITINIB (SUNITINIB MALATE) 12.5 MG | Marketed |
| 02280817 | SUTENT | PFIZER CANADA ULC | Capsule | SUNITINIB (SUNITINIB MALATE) 50 MG | Marketed |
| 02280795 | SUTENT | PFIZER CANADA ULC | Capsule | SUNITINIB (SUNITINIB MALATE) 12.5 MG | Marketed |
| 02280809 | SUTENT | PFIZER CANADA ULC | Capsule | SUNITINIB (SUNITINIB MALATE) 25 MG | Marketed |
| 02524082 | TARO-SUNITINIB | TARO PHARMACEUTICALS INC | Capsule | SUNITINIB (SUNITINIB MALATE) 50 MG | Marketed |
| 02524074 | TARO-SUNITINIB | TARO PHARMACEUTICALS INC | Capsule | SUNITINIB (SUNITINIB MALATE) 37.5 MG | Approved |
| 02524066 | TARO-SUNITINIB | TARO PHARMACEUTICALS INC | Capsule | SUNITINIB (SUNITINIB MALATE) 25 MG | Marketed |
| 02526204 | TEVA-SUNITINIB | TEVA CANADA LIMITED | Capsule | SUNITINIB (SUNITINIB MALATE) 12.5 MG | Marketed |
| 02526212 | TEVA-SUNITINIB | TEVA CANADA LIMITED | Capsule | SUNITINIB (SUNITINIB MALATE) 25 MG | Marketed |
| 02526220 | TEVA-SUNITINIB | TEVA CANADA LIMITED | Capsule | SUNITINIB (SUNITINIB MALATE) 50 MG | Marketed |
| 02328607 | SUTENT | PFIZER CANADA ULC | Capsule | SUNITINIB (SUNITINIB MALATE) 37.5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27348 | 2022-01-07 | Abbreviated New Drug Submission (ANDS) |